Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
15 mrt 2007 - 14:05
Statutaire naam
Crucell N.V.
Titel
Crucell Announces PER.C6® Licensing Agreement with Pfizer Animal Health
Bericht
Leiden, The Netherlands, March 15, 2007– Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) and Pfizer Animal Health today announced the signing of a research license agreement for PER.C6®. The license agreement allows Pfizer Animal Health to use Crucell’s industry-leading PER.C6® cell technology in the production of a non-disclosed veterinary vaccine. Pfizer Animal Health has an option to convert the research license into a commercial agreement. Financial details were not disclosed.
Gerelateerde downloads
Datum laatste update: 01 september 2024